|
[1]
|
Shi, S.H., Li, W.A., Ni, G.T., Ding, J., et al. (2024) Primary Lymphoma of the Female Genital Tract Masquerading as Gynecological Malignancy. BMC Women’s Health, 24, Article No. 247.
|
|
[2]
|
张颐, 田东立, 李芳梅, 等. 女性生殖道弥漫大B细胞淋巴瘤诊治的中国专家共识(2023年版) [J]. 癌症进展, 2023, 21(10): 1045-1049+1053.
|
|
[3]
|
Pirosa, M.C., Steffanoni, S., Vanazzi, A., Esposito, F., Polino, A., et al. (2024) Superior Prognostic Accuracy of FIGO Staging System in Primary Female Genital Tract Lymphomas: A Retrospective Study (IELSG35). Hematological Oncology, 42, e3312.
|
|
[4]
|
Ahmad, A.K., Hui, P., Litkouhi, B., Azodi, M., Rutherford, T., McCarthy, S., et al. (2014) Institutional Review of Primary Non-Hodgkin Lymphoma of the Female Genital Tract: A 33-Year Experience. International Journal of Gynecological Cancer, 24, 1250-1255. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Peng, F., Li, J.W., Mu, S.D., et al. (2022) Epidemiological Features for Primary Lymphoma of the Female Genital Tract Patients and Development of a Nomogram to Predict Survival. Annals of Medicine, 54, 962-976. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
肖会廷, 王珂. 原发于女性生殖系统非霍奇金淋巴瘤的诊断及治疗进展[J]. 中国肿瘤临床, 2020, 47(10): 530-534.
|
|
[7]
|
He, M., Hu, S. and Luo, H. (2020) Ultrasound Diagnosis and Clinicopathological Traits of Female Genital System Malignant Lymphomas. Medicine, 99, e21341. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
史瑞, 温静, 吴雯, 等. Ki-67、肿瘤坏死因子-α及糖类抗原125在非霍奇金淋巴瘤患者中的表达及临床意义[J]. 癌症进展, 2022, 20(24): 2575-2578.
|
|
[9]
|
沈明虹, 段华. 原发女性生殖道淋巴瘤11例临床分析[J]. 实用妇产科杂志, 2021, 37(9): 694-698.
|
|
[10]
|
刘文霞, 王晓雪, 何涛. 血清CRP、LDH水平及贫血与难治性或复发性非霍奇金淋巴瘤预后关系的探讨[J]. 癌症进展, 2020, 18(4): 397-401.
|
|
[11]
|
Jia, Q.C., Tang, H.M., Dong, Z.Y., et al. (2024) Malignant Primary Female Genital System Lymphoid. Frontiers in Oncology, 14, Article 1438812. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
徐兵, 赵海军. 《老年弥漫大B细胞淋巴瘤诊断与治疗专家共识(2024年版)》解读[J]. 临床血液学杂志, 2024, 37(5): 291-294.
|
|
[13]
|
赵倩, 严香, 张雅月. 弥漫性大B细胞淋巴瘤的中医研究现状与思考[J]. 河北中医, 2023, 45(7): 1218-1222.
|
|
[14]
|
Chen, F., Chen, J., Luo, D., Zhang, R., Yang, Y., Li, Q., et al. (2025) Prognosis and Clinicopathological Features of Patients with Early-Onset and Late-Onset Colorectal Cancer with Second Primary Malignancies. Journal of Gastroenterology and Hepatology, 40, 133-141. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Chen, S., Zhang, Y., Li, X., Tang, N. and Zeng, Y. (2025) Drug-Induced Second Tumors: A Disproportionality Analysis of the FAERS Database. Discover Oncology, 16, Article No. 786. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
VanderWalde, A.M. and Hurria, A. (2011) Second Malignancies among Elderly Survivors of Cancer. The Oncologist, 16, 1572-1581. [Google Scholar] [CrossRef] [PubMed]
|